P-768 Phase II study of irinotecan/cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide/cisplatin chemotherapy for limited disease small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(05)81261-9 ◽

2005 ◽

Vol 49 ◽

pp. S321

Author(s):

J. Han ◽

K. Cho ◽

D. Lee ◽

H. Kim ◽

E. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Limited Disease ◽

Thoracic Irradiation

Download Full-text

Phase II Study of Etoposide and Cisplatin With Concurrent Twice-Daily Thoracic Radiotherapy Followed by Irinotecan and Cisplatin in Patients With Limited-Disease Small-Cell Lung Cancer: West Japan Thoracic Oncology Group 9902

Yearbook of Oncology ◽

10.1016/s1040-1741(08)79221-2 ◽

2008 ◽

Vol 2008 ◽

pp. 171-173

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Limited Disease

Download Full-text

A Phase II Study of Combined Chemoradiotherapy for Limited Disease–Small-Cell Lung Cancer

American Journal of Clinical Oncology ◽

10.1097/00000421-200004000-00018 ◽

2000 ◽

Vol 23 (2) ◽

pp. 197-202 ◽

Cited By ~ 1

Author(s):

Shinichi Ishihara ◽

Satoshi Tsuchiya ◽

Koichi Minato ◽

Satoru Watanabe ◽

Noriaki Sunaga ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Limited Disease ◽

Combined Chemoradiotherapy

Download Full-text

P-792 Phase II study of cisplatin plus etoposide over 3 days combinedwith irinotecan and early thoracic radiotherapy (TRT) in patients with limited disease (LD) small cell lung cancer (SCLC), preliminary results

Lung Cancer ◽

10.1016/s0169-5002(05)81285-1 ◽

2005 ◽

Vol 49 ◽

pp. S327 ◽

Cited By ~ 1

Author(s):

E. Samantas ◽

K. Syrigos ◽

E. Briassoulis ◽

A. Bamias ◽

A. Koutras ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Limited Disease ◽

Preliminary Results

Download Full-text

Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

Annals of Oncology ◽

10.1023/a:1012295131640 ◽

2001 ◽

Vol 12 (9) ◽

pp. 1231-1238 ◽

Cited By ~ 73

Author(s):

D.V. Skarlos ◽

E. Samantas ◽

E. Briassoulis ◽

E. Panoussaki ◽

N. Pavlidis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Limited Disease ◽

Thoracic Irradiation ◽

Randomized Phase Ii

Download Full-text

Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2006.06.002 ◽

2006 ◽

Vol 53 (3) ◽

pp. 361-366 ◽

Cited By ~ 15

Author(s):

Hye Cheol Jeong ◽

Sang Yeub Lee ◽

Sung Yong Lee ◽

Je Hyeong Kim ◽

Chol Shin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Limited Disease ◽

Concurrent Radiotherapy

Download Full-text

1137 POSTER Phase II study of carboplatin and irinotecan (CPT-11) in patients with limited disease small cell lung cancer (SCLC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81431-4 ◽

2005 ◽

Vol 3 (2) ◽

pp. 328

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Limited Disease

Download Full-text

A Phase II Study of VP-16-Ifosfamide-Cisplatin Combination Chemotherapy Plus Early Concurrent Thoracic Irradiation for Previously Untreated Limited Small Cell Lung Cancer

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyd135 ◽

2000 ◽

Vol 30 (12) ◽

pp. 542-546 ◽

Cited By ~ 8

Author(s):

I. S. Woo

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Combination Chemotherapy ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Thoracic Irradiation

Download Full-text

P-58 Phase II study of irinotecan/cisplatin (IP) induction chemotherapy followed by concurrent twice-daily thoracic radiotherapy (RT) with etoposide/cisplatin (EP) for limited disease small cell lung cancer (LD-SCLC)

Lung Cancer ◽

10.1016/s0169-5002(03)92027-7 ◽

2003 ◽

Vol 41 ◽

pp. S105

Author(s):

Ji-Youn Han ◽

Kwan Ho Cho ◽

Dae Ho Lee ◽

Seong Min Yoon ◽

Hyae Young Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Limited Disease

Download Full-text

Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1952-5 ◽

2012 ◽

Vol 70 (5) ◽

pp. 645-651 ◽

Cited By ~ 6

Author(s):

Minoru Fukuda ◽

Yoichi Nakamura ◽

Akitoshi Kinoshita ◽

Yoshifumi Soejima ◽

Hiroyuki Yamaguchi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Limited Disease ◽

Split Course Radiotherapy

Download Full-text

A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC)

Lung Cancer ◽

10.1016/j.lungcan.2007.03.001 ◽

2007 ◽

Vol 57 (2) ◽

pp. 181-186 ◽

Cited By ~ 4

Author(s):

Eckart Laack ◽

Ina Thöm ◽

Andreas Krüll ◽

Walburga Engel-Riedel ◽

Thomas Müller ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Limited Disease

Download Full-text